Acrux heads to the Finnish
Thursday, 14 August, 2008
Acrux [ASX: ACR] has entered into a manufacturing alliance with the Finnish Orion Corporation.
Under the agreement, Orion will become the exclusive manufacturer for Acrux's Testosterone MD-Lotion, as well as a range of transdermal spray products under development.
Acrux retains the rights to supply the products to licensees in all territories.
Both parties will invest in additional equipment at Orion's manufacturing facility as part of the alliance.
Scientists find new driver of ovarian cancer spread
A cell surface receptor known as F2R could serve as both a diagnostic marker for ovarian cancer...
Hormone therapy shifts body proteins to match gender identity
Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...
Targeting 'molecular bodyguards' weakens prostate cancer cells
Research reveals that two enzymes — PDIA1 and PDIA5 — act as 'molecular...
